Clinical trials
Phase 2 Bronchiectasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 5 |
| Unknown status | 4 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 3 |
| AstraZeneca | 2 |
| Bayer | 2 |
| Insmed Incorporated | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| Belfast Health and Social Care Trust | 1 |
| Centre Hospitalier Intercommunal Creteil | 1 |
| Federal State Budgetary Institution, Pulmonology Scientific Research Institute | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiectasis | 30 |
| Cystic Fibrosis | 3 |
| Lung Diseases | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Asthma | 2 |
| Pseudomonas Infections | 2 |
| Respiratory Tract Diseases | 2 |
| Bronchitis, Chronic | 1 |
| Fibrosis | 1 |
| Hypoxia | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.